Skip to main content
Top
Published in: Respiratory Research 1/2024

Open Access 01-12-2024 | Hypersensitivity Pneumonitis | Research

Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis

Authors: Tananchai Petnak, Wisit Cheungpasitporn, Charat Thongprayoon, Tulaton Sodsri, Supawit Tangpanithandee, Teng Moua

Published in: Respiratory Research | Issue 1/2024

Login to get access

Abstract

Background

Patients with fibrotic hypersensitivity pneumonitis (f-HP) have varied clinical and radiologic presentations whose associated phenotypic outcomes have not been previously described. We conducted a study to evaluate mortality and lung transplant (LT) outcomes among clinical clusters of f-HP as characterized by an unsupervised machine learning approach.

Methods

Consensus cluster analysis was performed on a retrospective cohort of f-HP patients diagnosed according to recent international guideline. Demographics, antigen exposure, radiologic, histopathologic, and pulmonary function findings along with comorbidities were included in the cluster analysis. Cox proportional-hazards regression was used to assess mortality or LT risk as a combined outcome for each cluster.

Results

Three distinct clusters were identified among 336 f-HP patients. Cluster 1 (n = 158, 47%) was characterized by mild restriction on pulmonary function testing (PFT). Cluster 2 (n = 46, 14%) was characterized by younger age, lower BMI, and a higher proportion of identifiable causative antigens with baseline obstructive physiology. Cluster 3 (n = 132, 39%) was characterized by moderate to severe restriction. When compared to cluster 1, mortality or LT risk was lower in cluster 2 (hazard ratio (HR) of 0.42; 95% CI, 0.21–0.82; P = 0.01) and higher in cluster 3 (HR of 1.76; 95% CI, 1.24–2.48; P = 0.001).

Conclusions

Three distinct phenotypes of f-HP with unique mortality or transplant outcomes were found using unsupervised cluster analysis, highlighting improved mortality in fibrotic patients with obstructive physiology and identifiable antigens.
Appendix
Available only for authorised users
Literature
1.
go back to reference Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, et al. Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202:e36–e69.CrossRefPubMedPubMedCentral Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, et al. Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202:e36–e69.CrossRefPubMedPubMedCentral
2.
go back to reference Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196:680–9.CrossRefPubMed Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196:680–9.CrossRefPubMed
3.
go back to reference Fernández Pérez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Annals of the American Thoracic Society. 2018;15:460–9.CrossRefPubMed Fernández Pérez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Annals of the American Thoracic Society. 2018;15:460–9.CrossRefPubMed
4.
go back to reference Fernandez Perez ER, Swigris JJ, Forssen AV, Tourin O, Solomon JJ, Huie TJ, Olson AL, Brown KK. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644–51.CrossRefPubMedPubMedCentral Fernandez Perez ER, Swigris JJ, Forssen AV, Tourin O, Solomon JJ, Huie TJ, Olson AL, Brown KK. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644–51.CrossRefPubMedPubMedCentral
5.
go back to reference Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, et al. Hypersensitivity pneumonitis: radiologic phenotypes are Associated with distinct survival time and pulmonary function trajectory. Chest. 2019;155:699–711.CrossRefPubMed Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, et al. Hypersensitivity pneumonitis: radiologic phenotypes are Associated with distinct survival time and pulmonary function trajectory. Chest. 2019;155:699–711.CrossRefPubMed
6.
go back to reference Rodriguez MZ, Comin CH, Casanova D, Bruno OM, Amancio DR, Costa LDF, Rodrigues FA. Clustering algorithms: a comparative approach. PLoS ONE. 2019;14:e0210236.CrossRefPubMedPubMedCentral Rodriguez MZ, Comin CH, Casanova D, Bruno OM, Amancio DR, Costa LDF, Rodrigues FA. Clustering algorithms: a comparative approach. PLoS ONE. 2019;14:e0210236.CrossRefPubMedPubMedCentral
7.
8.
go back to reference Wong AW, Lee TY, Johannson KA, Assayag D, Morisset J, Fell CD, Fisher JH, Shapera S, Gershon AS, Cox G, et al. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease. Respir Res. 2020;21:322.CrossRefPubMedPubMedCentral Wong AW, Lee TY, Johannson KA, Assayag D, Morisset J, Fell CD, Fisher JH, Shapera S, Gershon AS, Cox G, et al. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease. Respir Res. 2020;21:322.CrossRefPubMedPubMedCentral
9.
go back to reference Stekhoven DJ, Buhlmann P. MissForest–non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–8.CrossRefPubMed Stekhoven DJ, Buhlmann P. MissForest–non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–8.CrossRefPubMed
10.
go back to reference Monti S, Tamayo P, Mesirov J, Golub T. Consensus Clustering: a resampling-based method for Class Discovery and visualization of gene expression microarray data. Mach Learn. 2003;52:91–118.CrossRef Monti S, Tamayo P, Mesirov J, Golub T. Consensus Clustering: a resampling-based method for Class Discovery and visualization of gene expression microarray data. Mach Learn. 2003;52:91–118.CrossRef
11.
13.
go back to reference De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Verleden GM, Wuyts WA. Effects of Corticosteroid Treatment and Antigen Avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. J Clin Med 2018, 8. De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Verleden GM, Wuyts WA. Effects of Corticosteroid Treatment and Antigen Avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. J Clin Med 2018, 8.
14.
go back to reference Moua T, Petnak T, Charokopos A, Baqir M, Ryu JH. Challenges in the diagnosis and management of Fibrotic Hypersensitivity Pneumonitis: a practical review of current approaches. J Clin Med 2022, 11. Moua T, Petnak T, Charokopos A, Baqir M, Ryu JH. Challenges in the diagnosis and management of Fibrotic Hypersensitivity Pneumonitis: a practical review of current approaches. J Clin Med 2022, 11.
15.
go back to reference Ojanguren I, Morell F, Ramon MA, Villar A, Romero C, Cruz MJ, Munoz X. Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy. 2019;74:944–52.CrossRefPubMed Ojanguren I, Morell F, Ramon MA, Villar A, Romero C, Cruz MJ, Munoz X. Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy. 2019;74:944–52.CrossRefPubMed
16.
go back to reference Dias OM, Baldi BG, Chate RC, Ribeiro de Carvalho CR, Dellaca RL, Milesi I, Pereira de Albuquerque AL. Forced oscillation technique and small Airway involvement in chronic hypersensitivity pneumonitis. Arch Bronconeumol (Engl Ed). 2019;55:519–25.CrossRefPubMed Dias OM, Baldi BG, Chate RC, Ribeiro de Carvalho CR, Dellaca RL, Milesi I, Pereira de Albuquerque AL. Forced oscillation technique and small Airway involvement in chronic hypersensitivity pneumonitis. Arch Bronconeumol (Engl Ed). 2019;55:519–25.CrossRefPubMed
17.
go back to reference Guerrero Zuniga S, Sanchez Hernandez J, Mateos Toledo H, Mejia Avila M, Gochicoa-Rangel L, Miguel Reyes JL, Selman M, Torre-Bouscoulet L. Small airway dysfunction in chronic hypersensitivity pneumonitis. Respirology. 2017;22:1637–42.CrossRefPubMed Guerrero Zuniga S, Sanchez Hernandez J, Mateos Toledo H, Mejia Avila M, Gochicoa-Rangel L, Miguel Reyes JL, Selman M, Torre-Bouscoulet L. Small airway dysfunction in chronic hypersensitivity pneumonitis. Respirology. 2017;22:1637–42.CrossRefPubMed
18.
go back to reference Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CAC. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73:391–2.CrossRefPubMed Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CAC. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73:391–2.CrossRefPubMed
Metadata
Title
Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis
Authors
Tananchai Petnak
Wisit Cheungpasitporn
Charat Thongprayoon
Tulaton Sodsri
Supawit Tangpanithandee
Teng Moua
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2024
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-024-02664-x

Other articles of this Issue 1/2024

Respiratory Research 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.